Literature DB >> 22463829

Why does my patient have leukocytosis?

Jan Cerny1, Alan G Rosmarin.   

Abstract

Leukocytosis is one of the most common laboratory abnormalities in medicine, and one of the most frequent reasons for hematologic consultation. Effective evaluation of leukocytosis requires an attentive history, careful physical examination, meticulous review of the complete blood count and peripheral blood smear, judicious application of laboratory and radiologic testing, and thoughtful analysis. Definitive diagnosis may require bone marrow aspiration and biopsy, imaging studies, and specialized molecular tests. The differential diagnosis of leukocytosis includes physiologic responses to a broad range of infectious and inflammatory processes, as well as numerous primary hematologic disorders such as leukemias, lymphomas, and myeloproliferative neoplasms.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22463829     DOI: 10.1016/j.hoc.2012.01.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  5 in total

Review 1.  Secondary peritonitis: principles of diagnosis and intervention.

Authors:  James T Ross; Michael A Matthay; Hobart W Harris
Journal:  BMJ       Date:  2018-06-18

2.  Hepatic Steatosis Is Associated with High White Blood Cell and Platelet Counts.

Authors:  Yu-Lin Chao; Pei-Yu Wu; Jiun-Chi Huang; Yi-Wen Chiu; Jia-Jung Lee; Szu-Chia Chen; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Biomedicines       Date:  2022-04-13

3.  Evaluation of Scopio Labs X100 Full Field PBS: The first high-resolution full field viewing of peripheral blood specimens combined with artificial intelligence-based morphological analysis.

Authors:  Ben-Zion Katz; Michael D Feldman; Minychel Tessema; Dan Benisty; Grace Stewart Toles; Alicia Andre; Bronka Shtreker; Fatima Maria Paz; Joshua Edwards; Darrin Jengehino; Adam Bagg; Irit Avivi; Olga Pozdnyakova
Journal:  Int J Lab Hematol       Date:  2021-09-21       Impact factor: 3.450

4.  Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact.

Authors:  Zhen Su; Yan-Ping Mao; Pu-Yun OuYang; Jie Tang; Fang-Yun Xie
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

5.  PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).

Authors:  Thomas Grellety; Sophie Cousin; Louis Letinier; Pauline Bosco-Lévy; Stéphanie Hoppe; Damien Joly; Nicolas Penel; Simone Mathoulin-Pelissier; Antoine Italiano
Journal:  BMC Cancer       Date:  2016-10-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.